Population pharmacokinetics of vancomycin in patients with diabetic foot infection: a comparison of five models

Hedieh Tazerouni; Zohre Labbani-Motlagh; Shahideh Amini; Bita Shahrami; Sayed Mahmoud Sajjadi-Jazi; Shirin Afhami; Kheirollah Gholami; Kourosh Sadeghi

doi:10.1007/s40200-023-01259-5

Population pharmacokinetics of vancomycin in patients with diabetic foot infection: a comparison of five models

J Diabetes Metab Disord. 2023 Jul 10;22(2):1385-1390. doi: 10.1007/s40200-023-01259-5. eCollection 2023 Dec.

Authors

Hedieh Tazerouni^{1

2}, Zohre Labbani-Motlagh³, Shahideh Amini³, Bita Shahrami³, Sayed Mahmoud Sajjadi-Jazi^{4

5}, Shirin Afhami⁶, Kheirollah Gholami^{2

3}, Kourosh Sadeghi^{2

3}

Affiliations

¹ Department of Clinical Pharmacy, International Campus, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
² Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran.
³ Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
⁴ Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
⁵ Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
⁶ Department of Infectious Disease, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 37975097
PMCID: PMC10638227 (available on 2024-07-10)
DOI: 10.1007/s40200-023-01259-5

Abstract

Purpose: This study aimed to compare individual pharmacokinetic (PK) parameters of vancomycin with predicted values from five population PK models in patients with diabetic foot infections (DFIs).

Methods: Patients with a diagnosis of DFI and an estimated glomerular filtration rate (eGFR) ≥ 30 mL/min were included in the study. Individual PK data was carried on by collecting three vancomycin serum concentrations in a steady-state condition. Five published population-based nomograms were assumed to predict PK parameters. Optimal vancomycin exposure was considered as a trough level of 15-20 mg/L or the area under the curve over 24 h/minimum inhibitory concentration (AUC₂₄/MIC) ≥ 400.

Results: A total of 48 samples from 16 patients were analyzed. There was a statistically significant difference between the volume of distribution (V_d) obtained from population methods and the individual estimations (P ≤ 0.001 in Ambrose and Burton, P = 0.010 and 0.006 in Bauer and Burton revised models, respectively). AUC/MIC ≥ 400 was achieved in 68.7% of patients while 50% had a trough level of less than 15 mg/L.

Conclusions: Vancomycin PK parameters, particularly individualized V_d, may not be predictable by population nomograms in patients with DFI and stable renal function. Moreover, the weak correlation between AUC₂₄ values and trough concentrations underlines the starting practice of vancomycin AUC₂₄-based monitoring and dosing in the clinical setting.

Keywords: Area under the curve (AUC); Diabetic Foot infection; Methicillin-resistant Staphylococcus aureus (MRSA); Pharmacokinetics; Therapeutic drug monitoring (TDM); Vancomycin.

© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.